Nature biotechnology
-
Nature biotechnology · Jan 2008
ReviewAllergenicity assessment of genetically modified crops--what makes sense?
GM crops have great potential to improve food quality, increase harvest yields and decrease dependency on certain chemical pesticides. Before entering the market their safety needs to be scrutinized. ⋯ However, not all tests currently being applied to assessing allergenicity have a sound scientific basis. Recent events with transgenic crops reveal the fallacy of applying such tests to GM crops.
-
Given that Californian voters authorized state coffers to sell $3 billion in bonds to fund the California Institute for Regenerative Medicine (CIRM) with the expectation of health and financial benefits, what benchmarks should be used to measure the initiative's success?
-
Nature biotechnology · Feb 2007
ReviewManaging conflicts of interest: a survival guide for biotechs.
Conflicts of interest in research can affect a company's ability to move a product through the approval processor attract investment. Avoid the pitfalls by taking pro-active steps to manage these risks.
-
Nature biotechnology · Jan 2007
ReviewAnimal cloning and the FDA--the risk assessment paradigm under public scrutiny.
The evidence gathered thus far--ultimately to be published in the Draft Risk Assessment on Animal Cloning--indicates that there are no unique risks associated with animal cloning.